FOCUSING on IMPROVING THE LIVES of PATIENTS

WITH DIFFICULT-TO-TREAT DISEASES

RECENT NEWS

BioMed Valley Discoveries announces participation in NCI-MATCH studies utilizing their first-in-class ERK inhibitor. See details here.

July 25, 2019

COMBINING the EXPERTISE of our TEAM and our PARTNERS to BREAK THROUGH BARRIERS in EARLY STAGE DRUG DEVELOPMENT